KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 119 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $7,383,000 | +50.8% | 388,766 | 0.0% | 0.92% | -34.7% |
| Q3 2020 | $4,895,000 | +4.1% | 388,766 | 0.0% | 1.41% | -63.8% |
| Q2 2020 | $4,704,000 | +58.2% | 388,766 | 0.0% | 3.90% | +24.2% |
| Q1 2020 | $2,974,000 | -57.0% | 388,766 | 0.0% | 3.14% | +5.3% |
| Q4 2019 | $6,924,000 | +53.5% | 388,766 | 0.0% | 2.98% | +72.4% |
| Q3 2019 | $4,510,000 | -47.6% | 388,766 | 0.0% | 1.73% | -37.8% |
| Q2 2019 | $8,611,000 | -22.6% | 388,766 | 0.0% | 2.78% | -72.8% |
| Q1 2019 | $11,126,000 | +44.9% | 388,766 | 0.0% | 10.22% | -5.2% |
| Q4 2018 | $7,678,000 | -10.7% | 388,766 | 0.0% | 10.78% | +156.8% |
| Q3 2018 | $8,596,000 | +220.9% | 388,766 | +17.8% | 4.20% | +270.8% |
| Q2 2018 | $2,679,000 | -14.4% | 329,942 | 0.0% | 1.13% | -14.1% |
| Q1 2018 | $3,128,000 | -2.8% | 329,942 | 0.0% | 1.32% | +19.8% |
| Q4 2017 | $3,217,000 | +44.8% | 329,942 | 0.0% | 1.10% | +90.3% |
| Q3 2017 | $2,221,000 | -8.5% | 329,942 | 0.0% | 0.58% | +0.5% |
| Q2 2017 | $2,428,000 | -5.8% | 329,942 | 0.0% | 0.58% | +4.9% |
| Q1 2017 | $2,577,000 | +10.5% | 329,942 | 0.0% | 0.55% | -1.4% |
| Q4 2016 | $2,333,000 | – | 329,942 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 422,310 | $10,849,000 | 5.86% |
| COMMODORE CAPITAL LP | 214,467 | $5,510,000 | 2.20% |
| Vivo Capital, LLC | 1,863,296 | $47,868,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 214,533 | $5,486,000 | 1.45% |
| Nicholas Investment Partners, LP | 594,130 | $15,263,000 | 1.06% |
| Altium Capital Management LP | 128,130 | $3,292,000 | 0.91% |
| Affinity Asset Advisors, LLC | 100,000 | $2,569,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,000 | $1,285,000 | 0.70% |
| APIS CAPITAL ADVISORS, LLC | 30,000 | $771,000 | 0.70% |
| Birchview Capital, LP | 40,000 | $1,028,000 | 0.61% |